Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001890319 | SCV002150509 | likely benign | Myofibrillar myopathy 5; Distal myopathy with posterior leg and anterior hand involvement; Hypertrophic cardiomyopathy 26; Dilated Cardiomyopathy, Dominant | 2023-09-27 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004041263 | SCV005017720 | uncertain significance | Cardiovascular phenotype | 2024-02-10 | criteria provided, single submitter | clinical testing | The p.D646E variant (also known as c.1938T>A), located in coding exon 12 of the FLNC gene, results from a T to A substitution at nucleotide position 1938. The aspartic acid at codon 646 is replaced by glutamic acid, an amino acid with highly similar properties. This amino acid position is conserved. In addition, the in silico prediction for this alteration is inconclusive. Based on the available evidence, the clinical significance of this alteration remains unclear. |